Lupin, Neopharmed sign licensing pact for Gastro brand Plasil in Brazil, Philippines Ruchika Sharma18 Dec 2025 5:23 PM ISTPlasil is widely acknowledged for its efficacy in treating nausea, vomiting, and motility disorders.
Lupin receives positive EMA comittee opinion for eye therapy Ranluspec Ruchika Sharma17 Dec 2025 12:58 PM ISTMumbai: Global pharma major Lupin Limited has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines...
Lupin Nagpur injectable facility gets EIR from USFDA Ruchika Sharma17 Dec 2025 11:30 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has received the Establishment Inspection Report (EIR) from the United States...
Lupin secures SBTi validation for emission reduction targets Ruchika Sharma16 Dec 2025 10:30 AM ISTMumbai: Global pharma major Lupin Limited has announced that its greenhouse gas (GHG) emissions reduction targets have been officially validated by...
Lupin secures tentative USFDA nod for multiple sclerosis drug Siponimod Ruchika Sharma5 Dec 2025 11:10 AM ISTMumbai: Global pharma major Lupin Limited has announced that the company has received tentative approval from the United States Food and Drug...
Lupin enters into licensing agreement with Valorum for biosimilar Armlupeg in US Ruchika Sharma4 Dec 2025 2:14 PM ISTMumbai: Global pharma major Lupin Limited has announced that it has entered into an Exclusive Licensing Agreement with Valorum Biologics, a ...
Lupin secures USFDA nod for biosimilar Armlupeg Ruchika Sharma1 Dec 2025 10:48 AM ISTMumbai: Global pharma major Lupin Limited has announced that the United States Food and Drug Administration (U.S. FDA) has approved Armlupeg...
Lupin gets seven USFDA observations for Goa facility Ruchika Sharma22 Nov 2025 11:43 AM ISTMumbai: Lupin has announced that the company has received seven observations from the U.S. Food and Drug Administration (USFDA) after an...
Lupin secures S&P Global ESG Score of 91 for 2025 Ruchika Sharma17 Nov 2025 12:34 PM ISTMumbai: Global pharma firm Lupin Limited has announced that it has achieved an S&P Global ESG Score of 91 for 2025, well above the...
Lupin Nagpur facility completes USFDA inspection Ruchika Sharma15 Nov 2025 5:19 PM ISTMumbai: Global pharma major Lupin Limited has announced that the United States Food and Drug Administration (U.S. FDA) has completed a product...
Lupin unveils Risperidone Long Acting Injectable in US Ruchika Sharma14 Nov 2025 12:30 PM ISTMumbai: Global pharma major Lupin Limited has announced the launch of Risperidone for extended-release injectable suspension, 25 mg per vial,...
Lupin gets EIR from USFDA for Aurangabad Facility Ruchika Sharma13 Nov 2025 11:30 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has received the Establishment Inspection Report (EIR) from the United States Food and...
